Satoshi Inoue

Active 1985–2025

316
Papers
41,380
Citations
110
h-index
285
i10-index

Citations

Citations per year for Satoshi Inoue1985: 1 citations1986: 2 citations1987: 1 citations1988: 3 citations1989: 9 citations1990: 8 citations1991: 9 citations1992: 14 citations1993: 21 citations1994: 25 citations1995: 19 citations1996: 26 citations1997: 44 citations1998: 96 citations1999: 190 citations2000: 183 citations2001: 192 citations2002: 220 citations2003: 217 citations2004: 305 citations2005: 339 citations2006: 281 citations2007: 325 citations2008: 331 citations2009: 313 citations2010: 347 citations2011: 317 citations2012: 321 citations2013: 299 citations2014: 331 citations2015: 331 citations2016: 309 citations2017: 321 citations2018: 293 citations2019: 987 citations2020: 1,179 citations2021: 1,284 citations2022: 898 citations2023: 703 citations2024: 1,364 citations2025: 687 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,982 citing papers, 24.7% of this breakdownChina: 2,199 citing papers, 13.6% of this breakdownJapan: 1,162 citing papers, 7.2% of this breakdownUnited Kingdom: 937 citing papers, 5.8% of this breakdownGermany: 739 citing papers, 4.6% of this breakdownItaly: 700 citing papers, 4.3% of this breakdownCanada: 550 citing papers, 3.4% of this breakdownFrance: 471 citing papers, 2.9% of this breakdownAustralia: 344 citing papers, 2.1% of this breakdownSpain: 332 citing papers, 2.1% of this breakdownBrazil: 318 citing papers, 2% of this breakdownIndia: 318 citing papers, 2% of this breakdown
0%24.7%Other 25.3%

Fields

  • Biochemistry, Genetics and Molecular Biology36.4%
  • Medicine34.5%
  • Immunology and Microbiology10.2%
  • Dentistry6.6%
  • Materials Science2.6%
  • Engineering1.6%
  • Other8.1%

Topics

  • interferon and immune responses3.4%
  • Estrogen and related hormone effects2.5%
  • Dental materials and restorations2.2%
  • RNA modifications and cancer1.7%
  • Cancer-related molecular mechanisms research1.6%
  • Diabetes Treatment and Management1.5%
  • Other87.1%

Coauthors

All papers

Open in search
  1. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Satoshi Inoue, Taro Asakura, Marina V. Shestakova, Elena Khaykina, Е. А. Трошина, Н. В. Ворохобина, Ametov As, Shih‐Te Tu, Chwen-Yi Yang, I‐Te Lee, Chien‐Ning Huang, Horng‐Yih Ou, George Freeman, Sriram Machineni, Klara R. Klein, Senan Sultan, Alan A. Parsa, Juan Otero-Martinez, Alex Gonzalez, Anuj Bhargava, Susan Brian, Carlos Ince, Stephen Plantholt, Jeremy Cole, Audrey Lacour, Damaris Vega, José de Souza, Jane L. Rohlf, Roy C. St. John, Barry Horowitz, Hanid Audish, Rodolfo J. Galindo, Guillermo Umpiperrez, Jamy D. Ard, Brian R. Curtis, W. Timothy Garvey, Neil J. Fraser, Jose Mandry, Rizwana Mohseni, Ronald K. Mayfield, Talessa Powell, Carl Vance, Stephen Ong, Ana L. Lewy-Alterbaum, Alexander V. Murray, Amer Al‐Karadsheh, Tamer Yacoub, Kevin Roberts, David L. Fried, Julio Rosenstock, Bharathi Pulla, Bruce W. Bode, Juan P. Frías, Leslie J. Klaff, Ronald Brazg, Joanna Van, Anjanette Tan, Toby Briskin, Margaret Rhee, Tira Chaicha-Brom, Paul Hartley, Lazaro Nunez, Gregorio Cortes-Maisonet, Gary Soucie, Stanley H. Hsia, Thomas C. Jones, Stanley H. Hsia, Thomas C. Jones - The Lancet 2023 cited by 687

  2. Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Brož, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona‐Gutiérrez, Francesco Cecconi, Francis Ka-Ming Chan, Guoqiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos‐Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus‐Michael Debatin, Ralph J. DeBerardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian David Dynlacht, Wafik S. El‐Deiry, John W. Elrod, Kurt Engeland, Gian María Fimia, Claudia Galassi, Carlo Ganini, Ana J. García‐Sáez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Häcker, György Hajnóczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jäättelä, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala‐Devi Kanneganti and 128 more - Cell Death and Differentiation 2023 cited by 351

  3. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Ortiz, Enrique Villegas, Albina Golovach, Diana Alpenidze, Elena Frolova, Elena Zhdanova, Ludmila Ruyatkina, О. Б. Ершова, Ю. Г. Самойлова, S. T. Zyangirova, Katarina Lalić, Nebojša Lalić, Teodora Beljić Živković, Hayriye Esra Ataoğlu, Okan Bakıner, A. D. Dayan, Mehmet Sargın, Meral Mert, Mine Adaş, Ömür Tabak, Yüksel Altuntaş, Alexander V. Murray, Ali Iranmanesh, Aron Schlau, Bram Wieskopf, Brian D. Snyder, Carl J. Griffin, Charles Fogarty, Charles Lovell, Dale Allison, David Fitzpatrick, David Grant, David C. Klonoff, Dwayne Williams, Eddie Armas, Eileen M. Palace, Gary Ruoff, Gilbert Martinez, Gilberto Perez, Harold Bays, Horia Tatu, James Maynard, Jeanne-Elyse Cedeno, Vanita R. Aroda, Jean Park, Jennefer Sutton, Joe Pouzar, John Bertsch, Jonathan Condit, Jorge Serje, Josel Cabaccan, Joseph Risser, Juan P. Frías, Julio Rosenstock, Kanagaratnam Sivalingam, Kelli Maw, Lenita Hanson, Liana K. Billings, Lisa Connery, Mario Juarez, Michael Lillestol, Neil Fraser, Paul Beckett, Ralph Wade, Raul Gaona, Richard F. W. Jackson, Robert DeLuca, Sady Alpizar, Sharon J. Herring, Stanley Stringam and 5 more - Diabetes Care 2019 cited by 468

  4. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity

    Authors: , , , , , , , , , , - Nature 2007 cited by 1,711

  5. Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2015 cited by 986

  6. Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eleni Bekiari, Αlexandra Bargiota, Sanjay Agarwal, Banshi Saboo, Sanjay Chatterjee, Viswanathan Mohan, Shehla Shaikh, Yashdeep Gupta, Arpandev Bhattacharyya, Neeraj Manikath, Sunil Kumar, Takashi Sasaki, Takeshi Osonoi, Shuichi Fukuda, Seiki Wada, Arihiro Kiyosue, Yumiko Ide, Yukiko Onishi, Kiyokazu Matoba, Kuninobu Takai, Akira Yamauchi, Satoshi Inoue, Shizuka Kaneko, Hiroki Ikeda, Yasuharu Ohta, Akitaka Hisatomi, Takafumi Senokuchi, Hideaki Jinnouchi, Shuji Nakamura, José Roberto Lazcano Soto, Ignacio Rodríguez Briones, Paweł Bogdański, Ewa Szyprowska, Anna Modzelewska, Iwona Wozniak, S. T. Zyangirova, M. Sergeeva-Kondrachenko, Thomas R. A. Davis, Stephen P. Thomson, Juan P. Frías, Winston Gandy, Ildiko Lingvay, Kevin Pounds, Cynthia Bowman-Stroud, Michael Dempsey, David Huffman, Azazuddin Ahmed, Neil Fraser, Ramon Ortiz-Carrasquillo, D. Eric Bolster, Michael Adams, Matthew A. Hummel, Almena Free, Patricia Houser, Gerald Shockey, Otis Barnum, Kala R. Bhasker, George Mitchell Cornett, Dan Streja, William Kirby, Sean Lynd, Steven Folkerth, Samer Nakhle, Paul Norwood, Rodolfo Pérez, Brian D. Snyder, Neil Farris, Willian Litchfield, Osama Hamdy, Jean Park and 2 more - Diabetes Care 2019 cited by 282

  7. Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 cited by 223

  8. Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy

    Authors: , , , , , , , , , - Blood 2021 cited by 130

  9. Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I

    Authors: , , , , , , , , , - Cell Host & Microbe 2009 cited by 874

  10. Silk Fibroin of Bombyx mori Is Secreted, Assembling a High Molecular Mass Elementary Unit Consisting of H-chain, L-chain, and P25, with a 6:6:1 Molar Ratio

    Authors: , , , , , - Journal of Biological Chemistry 2000 cited by 781

  11. Functions of estrogen and estrogen receptor signaling on skeletal muscle

    Authors: , , - The Journal of Steroid Biochemistry and Molecular Biology 2019 cited by 197

  12. Roles of Estrogen, Estrogen Receptors, and Estrogen-Related Receptors in Skeletal Muscle: Regulation of Mitochondrial Function

    Authors: , , , - International Journal of Molecular Sciences 2023 cited by 131

  13. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities

    Authors: , , , , , , , , , , , , , , - Nature Cancer 2021 cited by 92

  14. Metabolic reprogramming during neuronal differentiation

    Authors: , , , , , , , , , - Cell Death and Differentiation 2016 cited by 268

  15. Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 60

  16. In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds

    Authors: , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2011 cited by 198

  17. Comparative Study on Adhesive Performance of Functional Monomers

    Authors: , , , , , , , , , , - Journal of Dental Research 2004 cited by 1,172

  18. BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 284

  19. Buonocore memorial lecture. Adhesion to enamel and dentin: current status and future challenges.

    Authors: , , , , , , , , - 2004 cited by 1,656

  20. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 139

  21. Inhibitory Effects of B Cells on Antitumor Immunity

    Authors: , , , - Cancer Research 2006 cited by 332

  22. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway

    Authors: , , , - Cell Death and Differentiation 2009 cited by 245

  23. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells

    Authors: , , , - Cells 2019 cited by 178

  24. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takashi Owa, Yasuhiro Funahashi, Yoichi Ozawa - Cancer Research 2021 cited by 61